World Congress of Gastroenterology

October 20, 2017October 20, 2017

Ozanimod Results Promising in Crohn’s Disease, Ulcerative Colitis, Phase 2 Trial Data Show

News

Celgene recently presented positive data from two Phase 2 studies — the STEPSTONE and TOUCHSTONE studies — for the company’s investigational compound ozanimod (RPC-1063) as a therapy for Crohn’s disease and ulcerative colitis ... Read more

October 10, 2017October 10, 2017

TiGenix Presents Positive Results of Potential Crohn’s Therapy, Announces Phase 3 Study

News

TiGenix will present positive results of Cx601 to treat complex perianal fistulas in Crohn’s disease patients at the upcoming World Congress of Gastroenterology ACG 2017 meeting in Orlando, Florida. The company will discuss ... Read more